DDX3X syndrome: From clinical phenotypes to biological insights
Journal of Neurochemistry · 2024-09 · 168 (9) · 2147-2154
DOI: 10.1111/jnc.16174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 08.07.2024. Verfasst von Alexa von Mueffling und 2 weiteren Autor:innen. Beteiligte Einrichtung: Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York City, New York, USA. Hauptthemen laut MEDLINE: DEAD-box RNA Helicases, Intellectual Disability. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NICHD NIH HHS, Eunice Kennedy Shriver National Institute of Child Health and Human Development.
Abstract (Originalsprache)
DDX3X syndrome is a neurodevelopmental disorder accounting for up to 3% of cases of intellectual disability (ID) and affecting primarily females. Individuals diagnosed with DDX3X syndrome can also present with behavioral challenges, motor delays and movement disorders, epilepsy, and congenital malformations. DDX3X syndrome is caused by mutations in the X‐linked gene DDX3X , which encodes a DEAD‐box RNA helicase with critical roles in RNA metabolism, including mRNA translation. Emerging discoveries from animal models are unveiling a fundamental role of DDX3X in neuronal differentiation and development, especially in the neocortex. Here, we review the current knowledge of genetic and neurobiological mechanisms underlying DDX3X syndrome and their relationship with clinical phenotypes. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Seaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
- Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
- The Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
- Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
- The Alper Center for Neural Development and Regeneration, Icahn School of Medicine at Mount Sinai, New York City, New York, USA.
- Barnard College, Columbia University, New York City, New York, USA.
ORCID-Profile: Silvia De Rubeis
Förderung
- NICHD NIH HHS
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
Zitieren
APA
von Mueffling, A., Garcia-Forn, M., & De Rubeis, S. (2024). DDX3X syndrome: From clinical phenotypes to biological insights. Journal of Neurochemistry, 168(9), 2147-2154. https://doi.org/10.1111/jnc.16174
Vancouver
von Mueffling A, Garcia-Forn M, De Rubeis S. DDX3X syndrome: From clinical phenotypes to biological insights. Journal of Neurochemistry. 2024;168(9):2147-2154. doi:10.1111/jnc.16174
BibTeX
@article{vonMueffling2024,
author = {von Mueffling, Alexa and Garcia-Forn, Marta and De Rubeis, Silvia},
title = {DDX3X syndrome: From clinical phenotypes to biological insights},
journal = {Journal of Neurochemistry},
year = {2024},
volume = {168},
number = {9},
pages = {2147--2154},
doi = {10.1111/jnc.16174}
}
EUVIMED